Developing Effective Cancer Survivorship Services

There are now almost 1.8 million people living in England who have had a diagnosis of cancer. This will increase to 3 million by 2030 as more people are diagnosed with cancer, treatment becomes more effective and people live longer after a cancer diagnosis. Evidence shows that many of these cancer survivors have unmet needs, particularly at the end of primary treatment, whilst others are struggling with consequences of treatment that could be either avoided or managed. The current system is failing to meet existing needs, and faces challenges in expanding sufficiently to support the increasing number of cancer survivors. Changing the way we support cancer survivors is therefore both an outcomes priority and a financial priority: simply doing more of the same will not deliver the outcome improvements we want “ National Cancer Survivorship Initiative 2014

Following on from the success of The National Cancer Survivorship Initiative (NCSI), NHS England has recently announced a new Living With and Beyond Cancer Programme. This programme is a two year partnership between NHS England and Macmillan Cancer Support and will develop and implement a transitional plan for the National Cancer Survivorship Initiative, aimed at embedding findings and recommendations into mainstream NHS commissioning and service provision. The programme will focus on
1.Ensuring all cancer patients have access to holistic needs assessment, treatment summary, cancer care review and a patient education and support event – the ‘Recovery Package.
2.Developing and commissioning risk stratified pathways of post treatment management. Promoting physical activity.
3.Understanding and commissioning for improved management of the consequences of treatment.

This conference focuses on cancer survivorship, improving outcomes for people living with and beyond cancer. Through national updates and practical case studies the conference aims to support you to develop effective cancer survivorship support and services.